Streetbeat News

Analyst Ratings

DELL

Dell shares are trading higher after Morgan Stanley reiterated a bullish rating on the stock.

Portfolio Pulse from Benzinga Newsdesk

June 17, 2024 | 2:11 pm

NRIX

JP Morgan analyst Eric Joseph maintains an Overweight rating on Nurix Therapeutics (NASDAQ:NRIX) and raises the price target from $30 to $31.

Portfolio Pulse from Benzinga Newsdesk

June 17, 2024 | 2:09 pm

INVH

JP Morgan analyst Anthony Paolone maintains a Neutral rating on Invitation Homes (NYSE:INVH) and raises the price target from $35 to $36.

Portfolio Pulse from Benzinga Newsdesk

June 17, 2024 | 2:07 pm

TTD

Wedbush analyst Scott Devitt initiates coverage on Trade Desk (NASDAQ:TTD) with an Outperform rating and sets a price target of $110.

Portfolio Pulse from Benzinga Newsdesk

June 17, 2024 | 2:06 pm

ESS

JP Morgan analyst Anthony Paolone maintains a Neutral rating on Essex Property Trust (NYSE:ESS) and raises the price target from $244 to $265.

Portfolio Pulse from Benzinga Newsdesk

June 17, 2024 | 2:05 pm

UROY

HC Wainwright & Co. has reiterated its Buy rating on Uranium Royalty (NASDAQ:UROY) and maintained a price target of $7.7.

Portfolio Pulse from Benzinga Newsdesk

June 17, 2024 | 2:03 pm

NYAX

Keefe, Bruyette & Woods has initiated coverage on Nayax (NASDAQ:NYAX) with a Market Perform rating and set a price target of $27.

Portfolio Pulse from Benzinga Newsdesk

June 17, 2024 | 2:03 pm

EQR

JP Morgan analyst Anthony Paolone maintains a Neutral rating on Equity Residential (NYSE:EQR) and raises the price target from $66 to $68.

Portfolio Pulse from Benzinga Newsdesk

June 17, 2024 | 2:03 pm

AGIO

Agios Pharmaceuticals (NASDAQ:AGIO) has been analyzed by 4 analysts in the last three months, showing a range of perspectives from bullish to bearish. The average 12-month price target has increased by 30.91% to $46.25. Key analysts from JP Morgan, Goldman Sachs, and RBC Capital have provided recent evaluations, with some raising their price targets.

Portfolio Pulse from Benzinga Insights

June 17, 2024 | 2:01 pm

LRCX

Significant options activity has been observed for Lam Research (NASDAQ:LRCX), with a notable bullish sentiment among deep-pocketed investors. This unusual activity suggests potential upcoming movements in LRCX's stock price. The trading volume and open interest indicate a focus on a price range between $380.0 and $1540.0. Analysts have mixed ratings, with a consensus target price of $1020.0.

Portfolio Pulse from Benzinga Insights

June 17, 2024 | 2:01 pm